newsfilter
← Latest News
GlobeNewswire·

CinCor Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

BrigHtn Phase 2 study with CIN-107 for Resistant Hypertension Enrollment Complete with Topline Results Expected in 2H 2022 Topline Data from HALO Phase 2 study with CIN-107 for Uncontrolled Hypertension Expected in 2H 2022 Mason Freeman, M.D. named